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Shalom Jacobovitz, Chief Executive Ofﬁcer, American College of CardiologyH igh-functioning, high-performance teamsare cohesive. They are united. They getthings done. To accomplish the American
College of Cardiology’s (ACC’s) mission to transform
cardiovascular care and improve heart health, we
must use the concept of high-functioning teams
as we partner with like-minded, mission-focused
organizations.
At the ACC’s “Heart House” headquarters in
Washington, DC, I have been working internally with
staff to ensure that the ACC is functioning as an
empowered organization with highly functioning
teams. We have developed an internal competency
model to ensure that all staff members and leaders
are striving for the same ideals. We are also working
to ensure that our objectives, from strategic ones to
individual ones, are aligned and working toward the
same goals. These partnerships and collaborations
allow the ACC to share knowledge and learn from
other groups in a way that, with each collaboration,
we inch closer to our goals.
This concept of high-performing teams also applies
to our external partnerships and collaborations. At
the ACC, we are part of a number of partnerships that
are making a real-world difference by positively
affecting cardiovascular care and improving the
health of populations. These partnerships are not
merely agreements on paper; they result in tangible
improvements as we jointly work toward common
achievable goals.
For the last 30 years, the ACC has partnered with
the American Heart Association to develop clinical
practice guidelines on 23 clinical topics across the
spectrum of cardiovascular diseases and procedures.
These guidelines are based on a shared commitment
of translating the best available scientiﬁc evidence
into clinical practice guidelines and performance
measures that can be used by healthcare professionalsCardiology, Washington, DC.to improve patient outcomes and quality cardiovas-
cular care. This year alone, we published or are
scheduled to publish 5 guidelines.
There are few partnerships as strong as the ones
involving the ACC’s National Cardiovascular Data
Registry—the suite of data registries helping hospitals
and private practices measure and improve the qual-
ity of cardiovascular care they provide. The success
of the registries in providing trusted and usable clin-
ical data for research, benchmarking, and quality
improvement is due in major part to our partnerships
with other medical specialty societies. To date, the
ACC is working with the Society for Cardiovascular
Angiography and Interventions (CathPCI Registry,
IMPACT Registry, and the PVI Registry); the Heart
Rhythm Society (ICD Registry); the American Acad-
emy of Pediatrics (IMPACT Registry; the Society of
Thoracic Surgeons/ACC TVT Registry); the American
Heart Association, with partnering support from the
Society of Cardiovascular Patient Care; and The
American College of Emergency Physicians (ACTION
Registry–GWTG Registry).
The College’s newest registry, the Diabetes
Collaborative Registry, is taking our registry part-
nerships to an even higher level. Designed through an
interdisciplinary collaboration led by the ACC and
AstraZeneca in partnership with the American Dia-
betes Association, the American College of Physi-
cians, and the Joslin Diabetes Center, this is the ﬁrst
global, cross-specialty, clinical diabetes registry de-
signed to track and improve the quality of diabetes
and cardiometabolic medicine across the primary and
specialty care continuum. This is truly a landmark
endeavor, with the ultimate goal being to provide a
unique, longitudinal view of the presentation, pro-
gression, management, and outcomes of patients
with diabetes as they receive care and treatment.
Outside of registries, the ACC is involved in several
partnerships focused on closing identiﬁed gaps and/
or reducing disparities in care. For example, the ACC
is part of the Cardiometabolic Health Alliance, which
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1858also includes the Association of Black Cardiologists,
American Association of Clinical Endocrinologists,
and the National Minority Quality Forum. The Alli-
ance is an interdisciplinary collaboration to improve
cardiometabolic risk factor control in diverse and
high-risk populations and to provide more effective
and coordinated care for patients with established
cardiometabolic disease.
Early this past summer, the Alliance held a Car-
dioMetabolic Think Tank, which was established
to address cardiometabolic disease and its inter-
dependencies and to identify a new care model that
takes an integrated approach to treating risk factors
across diverse populations. Participants discussed the
need for an integrated, coordinated, and interdis-
ciplinary approach to patient care, including risk
stratiﬁcation and staging, as well as targeted pre-
vention at key populations. Additional recommen-
dations and results from the Think Tank discussions
will be released in the future as an outcomes paper
from the partnering groups as a single, uniﬁed
alliance.
Other national partnerships focus on prevention
and making wise choices during treatment. A prime
example is the ACC’s involvement in the American
Board of Internal Medicine Foundation’s Choosing
Wisely Campaign. In 2012, the ACC joined 8 other
medical specialty societies in releasing specialty-
speciﬁc lists of things that physicians and patients
should question. The College also partners with
Million Hearts, engaging the College’s outpatient
PINNACLE Registry to monitor progress toward
Million Hearts goals and provide feedback for per-
formance improvement, as well as collaborating
through the ACC’s CardioSmart program to reach
patients living with or at risk of heart disease with
the “ABCS”—aspirin as appropriate, blood pressure
control, cholesterol management, and smoking
cessation.
Our partnerships extend globally as well. Whether
it is providing support for global efforts to address
noncommunicable diseases (NCDs) or partnering with
local health systems and/or governments on cam-
paigns addressing major cardiovascular risk factors
like hypertension, obesity, and smoking, the College
continues to work alongside its International Chap-
ters and with other international medical societies to
improve population health.
NCDs account for nearly two-thirds of global
deaths, with cardiovascular disease making up the
highest proportion. Over the last several years, the
ACC has actively advised the United Nations on its
efforts to combat the NCD epidemic and reach the
global target of a 25% reduction in prematuremortality from NCDs by 2025. As a proud member of
the NCD Alliance, the ACC is working to support this
global target, as well as corresponding NCD targets
focused on high blood pressure, smoking cessation,
diabetes, obesity, and reliable access to medicines.
These goals are embedded in the World Health Or-
ganization’s global action plan against NCDs.
In a recent President’s Page, ACC President Patrick
O’Gara, MD, FACC, also highlighted the China Chapter
as an example of a partnership that is successfully
leading the way in patient education (1). In China,
smoking and hypertension are alarmingly prevalent,
and awareness and control of these 2 risk factors are
limited. In response to these trends, the China
Chapter has hosted patient education events during
the Great Wall Congress of Cardiology meeting, and
has also translated and distributed several of the
ACC’s CardioSmart fact sheets on various cardiovas-
cular disease risk factors. This fall, the ACC and the
Chinese Society of Cardiology are launching a major
new initiative to combat hypertension in China with
the release of a Mandarin language website, distri-
bution of essential educational materials for nurses
and patients, and a public health event where blood
pressure screening will be conducted to raise aware-
ness around hypertension management.
We also serve as collaborators with our ACC chap-
ters, councils, and sections as they tackle local and
specialty issues. On the grassroots advocacy front, the
College has been working closely with the Maryland
Chapter on imaging legislation to great success. The
Maryland Chapter worked extensively for 2 years to
develop an oversight system for all state hospitals
performing percutaneous coronary intervention. This
resulted in a momentous win for the Chapter, as the
Maryland Legislature passed a bill in May 2012
requiring a state agency to develop requirements
for peer or independent review, consistent with
guidelines, of difﬁcult or complicated cases and for
randomly selected cases for Maryland hospitals.
Additionally, our advocacy staff works closely with
chapters on making the voice of cardiovascular pro-
fessionals and patients known on the hot topic issues
of smoking legislation and pulse oximetry screening.
Additionally, the Center for Medicare and Medicaid
Innovation this year bestowed a $15.8 million grant
upon the SMARTCare pilot project designed by the
ACC’s Wisconsin and Florida Chapters. The goal of
the project is to reduce healthcare costs by providing
tools to help doctors and patients communicate about
options for their care while helping physicians apply
the latest guidelines to the decision-making process.
The College is working with the Chapters to help
manage the grant and ensure the project’s success.
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1859These are just a fraction of the many examples of
partnerships that the College has underway, both
internally and externally. Our work together is done
cohesively. We are united in purpose. We strive with
every partnership and interaction to uphold the
characteristics and ideals of performance as high-
functioning teams to ensure that our ﬁnal outcome
is a better environment for cardiovascular patients.
Moving forward, we will be even more focused on
establishing partnerships with tangible goals andbeneﬁts that best meet the goals outlined by our
strategic plan. Working with our partners, we will
continue to lead the way in ensuring members have
the best science, education, and tools at their disposal
to provide patients around the world with the best
care.
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